Clinical Trials Directory

Trials / Unknown

UnknownNCT03813017

Comprehensive Assessment of Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Ziv Hospital · Other Government
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Cardiovascular disease is a leading cause for morbidity and mortality in general population. The incidence of cardiovascular disease and their poor outcome is well documented in a broad spectrum of connective tissue diseases, especially in rheumatoid arthritis (RA). The risk of incident CVD is increased by 48% in patients with RA compared to the general population. RA is associated with 50% increase in the mortality in patients with cardiovascular disease (CVD). One reason is the more frequent cardiovascular risk factors in RA patients compared with the general population. Patients with RA have a high risk of premature cardiovascular disease (CVD). The aim of the present study is to assess whether there are non-invasive measures that might predict arteriosclerosis in RA patients.

Conditions

Timeline

Start date
2019-10-01
Primary completion
2020-03-01
Completion
2020-07-01
First posted
2019-01-23
Last updated
2019-07-10

Source: ClinicalTrials.gov record NCT03813017. Inclusion in this directory is not an endorsement.